FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
27,036,775
Share change
-673,655
Total reported value
$104,792,174
Price per share
$3.87
Number of holders
100
Value change
-$4,792,692
Number of buys
54
Number of sells
46

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q3 2019

As of 30 Sep 2019, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 100 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,036,775 shares. The largest 10 holders included BVF INC/IL, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, Man Group plc, RENAISSANCE TECHNOLOGIES LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Rock Springs Capital Management LP, and STATE STREET CORP. This page lists 100 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.